Literature DB >> 15138794

[Retinal vein branch occlusion and palsy of the N. abducens in protein S deficiency].

H M Holak1, N H Holak, S Holak, S A Holak, S Szymaniec.   

Abstract

BACKGROUND: Protein S deficiency, which exists in 0.7% of the population, is a risk factor for retinal vein branch occlusions and is inherited in an autosomal dominant manner.
METHODS: A genealogical study was carried out on three generations of one family who exhibited different venous occlusions and subsequent complications.
RESULTS: Four members of the family, spanning three generations, suffered from complications of venous thrombosis. In the first generation a great uncle died of complications from a deep leg venous thrombosis. In the second generation, the mother underwent a venous branch thrombosis at the age of 41 with a protein S activity of 18%. Subsequently, a palsy of the N. abducens developed with multiple cerebral lesions (presumably post-thrombotic) in the MRI. Fluorescein angiography showed a typical picture of a venous branch occlusion which had been treated by laser. In the third generation, the 16-year-old daughter developed iliac venous thrombosis and a pulmonary embolism with a protein S activity of 0%. The fluorescein angiography showed distinctively engorged veins. A 28-year-old daughter, with a protein S activity of 16%, remained asymptomatic, although fluorescein angiography demonstrated engorged veins. Protein C activity and APC resistance of all family members were normal. The chromosomal analysis of the family members revealed no morphological aberrations.
CONCLUSION: Protein S deficiency increases the risk of congenital thrombosis in young and middle-aged heterozygous individuals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15138794     DOI: 10.1007/s00347-004-1032-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  45 in total

1.  Neonatal purpura fulminans associated with homozygous protein S deficiency.

Authors:  C Mahasandana; V Suvatte; R A Marlar; M J Manco-Johnson; L J Jacobson; W E Hathaway
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

2.  Thrombin-antithrombin III complex in acute retinal vein occlusion.

Authors:  H Iijima; T Gohdo; M Imai; S Tsukahara
Journal:  Am J Ophthalmol       Date:  1998-11       Impact factor: 5.258

3.  Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations.

Authors:  S Aras; G Yilmaz; I Alpas; V Baltaci; E Tayanç; P Aydin
Journal:  Eur J Ophthalmol       Date:  2001 Oct-Dec       Impact factor: 2.597

4.  [Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and a healthy control group].

Authors:  S Faude; F Faude; A Siegemund; P Wiedemann
Journal:  Ophthalmologe       Date:  1999-09       Impact factor: 1.059

5.  [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].

Authors:  K Greiner; G Hafner; W Prellwitz; N Pfeiffer
Journal:  Klin Monbl Augenheilkd       Date:  1999-07       Impact factor: 0.700

6.  Factor V Leiden, activated protein C resistance, and retinal vein occlusion.

Authors:  A P Ciardella; L A Yannuzzi; K B Freund; D DiMichele; M Nejat; J T De Rosa; J R Daly; L Sisco
Journal:  Retina       Date:  1998       Impact factor: 4.256

7.  Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.

Authors:  B Bertram; A Remky; O Arend; S Wolf; M Reim
Journal:  Ger J Ophthalmol       Date:  1995-11

8.  Retinal vascular occlusion and deficiencies in the protein C pathway.

Authors:  K Greiner; G Hafner; B Dick; D Peetz; W Prellwitz; N Pfeiffer
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

Review 9.  The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions.

Authors:  A K Vine; M M Samama
Journal:  Surv Ophthalmol       Date:  1993 Jan-Feb       Impact factor: 6.048

10.  A mutation of the active protein S gene leading to an EGF1-lacking protein in a family with qualitative (type II) deficiency.

Authors:  C Leroy-Matheron; M Gouault-Heilmann; M Aiach; S Gandrille
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.